Shire deal to rebalance Takeda's global footprint

With an agreement to acquire Shire plc (LSE:SHP; NASDAQ:SHPG) now in hand, Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) is poised to expand its U.S. presence through the creation of a combined company that makes good on President and

Read the full 372 word article

User Sign In